title: A new class of nonpeptide bradykinin B(2) receptor ligand, incorporating a 4-aminoquinoline framework. Identification of a key pharmacophore to determine species difference and agonist/antagonist profile.
abstract: Introduction of various aliphatic amino groups at the 4-position of the quinoline moiety of our nonpeptide bradykinin (BK) B(2) receptor antagonists afforded highly potent ligands for human B(2) receptor with various affinities for guinea pig B(2) receptor, indicating remarkable species difference. A representative 4-dimethyamino derivative 40a exhibited subnanomolar and nanomolar binding affinities for human and guinea pig B(2) receptors, respectively, and significantly inhibited BK-induced bronchoconstriction in guinea pigs at 10 microg/kg by intravenous administration. Further chemical modification led us to discover unique partial agonists for the human B(2) receptor that increase inositol phosphates (IPs) production by themselves in Chinese hamster ovary (CHO) cells expressing the cloned human B(2) receptor. Although their potency and efficacy were much lower than those of BK, we identified them as screening leads for nonpeptide B(2) agonists. In these studies it was revealed the 4-substituent of the quinoline moiety is the key pharmacophore to determine species difference and agonist/antagonist profiles.
authors.affiliation: Exploratory Research Laboratories, Fujisawa Pharmaceutical Co Ltd, 5-2-3 Tokodai, Tsukuba, Ibaraki 300-2698, Japan.
authors.forename: Yuki
authors.initials: Y
authors.lastname: Sawada
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Kayakiri
authors.forename: Yoshito
authors.initials: Y
authors.lastname: Abe
authors.forename: Tsuyoshi
authors.initials: T
authors.lastname: Mizutani
authors.forename: Noriaki
authors.initials: N
authors.lastname: Inamura
authors.forename: Masayuki
authors.initials: M
authors.lastname: Asano
authors.forename: Ichiro
authors.initials: I
authors.lastname: Aramori
authors.forename: Chie
authors.initials: C
authors.lastname: Hatori
authors.forename: Teruo
authors.initials: T
authors.lastname: Oku
authors.forename: Hirokazu
authors.initials: H
authors.lastname: Tanaka
mesh_terms: D000818:Animals; D065094:Bradykinin B2 Receptor Antagonists; D016084:Bronchoconstriction / Q000187:drug effects; D016466:CHO Cells; D006224:Cricetinae; D006168:Guinea Pigs; D006801:Humans; D066298:In Vitro Techniques; D007295:Inositol Phosphates / Q000096:biosynthesis; D008024:Ligands; D011804:Quinolines / Q000138:chemical synthesis* / Q000737:chemistry / Q000494:pharmacology; D011869:Radioligand Assay; D043782:Receptor, Bradykinin B2 / Q000819:agonists*; D013045:Species Specificity; D013329:Structure-Activity Relationship
chemical_list: D065094:Bradykinin B2 Receptor Antagonists; D007295:Inositol Phosphates; D008024:Ligands; D011804:Quinolines; D043782:Receptor, Bradykinin B2